Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
about
Dual association by TFAP2A during activation of the p21cip/CDKN1A promoterThe Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation.Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cellsReverse transcriptase-coupled quantitative real time PCR analysis of cell-free transcription on the chromatin-assembled p21 promoterMultivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damageRegulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone MarrowInhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21Effects of histone acetylation and DNA methylation on p21( WAF1) regulationp21(waf) correlates with DNA replication but not with prognosis in invasive breast cancerThe CD40-autophagy pathway is needed for host protection despite IFN-Γ-dependent immunity and CD40 induces autophagy via control of P21 levelsThe basic helix-loop-helix protein BETA2 interacts with p300 to coordinate differentiation of secretin-expressing enteroendocrine cellsTranscriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53Transient expression of a winged-helix protein, MNF-beta, during myogenesisChromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators.Rad9 modulates the P21WAF1 pathway by direct association with p53.p53 induces distinct epigenetic states at its direct target promoters.Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trialSulforaphane Increases Cyclin-Dependent Kinase Inhibitor, p21 Protein in Human Oral Carcinoma Cells and Nude Mouse Animal Model to Induce G(2)/M Cell Cycle ArrestLocalisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritisAssociation between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis.Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturationViral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytesApoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesotheliomap53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization.The p53MH algorithm and its application in detecting p53-responsive genesExpression quantitative trait loci analysis of 13 genes in the rat prostate.The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutationsHuman RAD9 checkpoint control/proapoptotic protein can activate transcription of p21.Dual regulatory roles of human AP-endonuclease (APE1/Ref-1) in CDKN1A/p21 expressionFormation of stress-specific p53 binding patterns is influenced by chromatin but not by modulation of p53 binding affinity to response elementsp53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation.Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice.Expression of p53 target genes in the early phase of long-term potentiation in the rat hippocampal CA1 areaIdentification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrestPatterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomasLhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases
P2860
Q24307618-121ECF04-52BB-425F-859D-435D201EB416Q24310788-ED507647-5371-4996-9523-F5722491F4A7Q24522573-A7E67105-D5F7-4281-A92B-FB21A6421DBEQ24613365-AF3EB6DD-641B-4BB3-B3C7-6D6CD61365ECQ24655422-12A99426-23B3-4784-88C8-C14121553F1EQ25256835-66A6B3D9-B121-4129-9AEA-892EE1106D5CQ27853382-47DDB83B-8B34-4D28-AD1F-B45F7890C512Q28192797-51C52CB6-B826-443E-B313-1DD455687BFDQ28202424-D9D74F87-3FDF-4F12-9952-0E328FE12513Q28362835-3A6480DE-BFED-47A7-AD8A-4AB3C92099FBQ28476673-4085BA90-59FD-4205-B519-1BD526C00905Q28512414-71E06385-F9BB-43AA-A905-77D88C6004CCQ28552677-C170A617-6346-414D-A67D-60A9477F0BCDQ28587918-136FB373-B8CA-4A88-AE15-F7638A422E63Q33226324-A318E584-CEF2-4BD7-B265-C70A59E5BE16Q33285076-4D58F5A2-CC64-4B2D-86A3-1D01DDA46568Q33376888-361BB05C-DBC6-47F5-AE01-D1930FD2D353Q33513057-4BFF6958-6106-48C0-BE13-D09542B89812Q33577436-768DA1F5-708F-4D6B-A0AC-2B19A312C45BQ33579056-6B036568-6429-4784-B488-549F3A0BAA30Q33579485-DAC829D7-023C-4925-83EA-45FF41381CC8Q33601430-0AC3D3D9-0590-425A-8ECE-D981E9E1E27DQ33611148-26839210-A7AA-4224-9E51-5F3845A30095Q33782160-A7C129CF-C8C1-4808-A0D7-AED5C4FCEFF5Q33999822-19C4B938-B1F4-44D8-8372-D0E95B328645Q34001316-93FF41FB-6C51-4EFA-8AF2-10E80C78E4BCQ34064408-AAEDA889-D0E4-47B2-B07E-4E2C09A34E2CQ34589899-C0716EEC-BA63-4E0E-A960-E7F573527627Q34784078-4E5224F2-3696-4C54-B68D-B581425B86C7Q34828045-D57E21A6-7CAF-49CF-B94E-51671BD8466CQ34848804-0809488F-79C3-4293-A879-51318614CF64Q34865226-407CEE31-BFAE-401F-A199-448812E154B7Q35081442-EEB9B32B-17F0-4ED0-B2F5-B0CAAD82236CQ35083785-4060D0F6-FB86-459C-B73C-53C4D4805027Q35124631-F73DA0B1-ABAC-4C68-8607-7E45FAA45030Q35205701-12BAB545-26FA-4E89-A8D6-2FA43DD675B1Q35207580-77616A33-CF25-4F98-885D-137AEB2D9D6EQ35397887-8B3F60EB-2DFD-42C0-9BD1-2FA325A46853Q35441732-3D1B8260-CB0E-4293-BF32-3BD3418ABEFFQ35680797-C98FF06C-EE22-46A3-B975-1DD731E2338D
P2860
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
@en
type
label
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
@en
prefLabel
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
@en
P2093
P1433
P1476
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
@en
P2093
Hamilton SR
Velculescu VE
el-Deiry WS
P304
P407
P577
1995-07-01T00:00:00Z